Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of August 13, 2025 • 12:00 AM ET

Date/Time Source News Release
08/07/2025 04:01 PM EDT GlobeNewswire Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2025 Financial Results
07/31/2025 04:05 PM EDT GlobeNewswire Sangamo Therapeutics Announces Second Quarter 2025 Earnings Call
06/24/2025 08:05 AM EDT Business Wire Sangamo Therapeutics Announces Positive Topline Results From Registrational STAAR Study in Fabry Disease
05/12/2025 06:26 PM EDT Business Wire Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2025 Financial Results
05/12/2025 06:23 PM EDT Business Wire Sangamo Therapeutics Announces Pricing of $23.0 Million Underwritten Offering
05/12/2025 04:00 PM EDT Business Wire Sangamo Therapeutics Postpones First Quarter 2025 Conference Call to Later the Same Day
05/06/2025 04:35 PM EDT Business Wire Sangamo Therapeutics Announces First Quarter 2025 Earnings Call
05/06/2025 08:30 AM EDT Business Wire Sangamo Therapeutics Announces Important Derisking Milestones in Pathway to Anticipated BLA Submission for ST-920 in Fabry Disease
04/28/2025 04:31 PM EDT Business Wire Sangamo Therapeutics to Present Neurology Pipeline Advances at the 28th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
04/03/2025 04:01 PM EDT Business Wire Sangamo Therapeutics Announces Capsid License Agreement With Lilly to Deliver Genomic Medicines for Diseases of the Central Nervous System
Page

Additional News

As of August 13, 2025 • 12:00 AM ET

Date/Time Source News Release
08/08/2025 02:53 PM EDT SeekingAlpha Sangamo Therapeutics, Inc. (SGMO) Q2 2025 Earnings Call Transcript
08/07/2025 05:40 PM EDT Zacks Sangamo Therapeutics (SGMO) Reports Q2 Loss, Lags Revenue Estimates
08/07/2025 04:04 PM EDT SeekingAlpha Sangamo Therapeutics GAAP EPS of -$0.08 misses by $0.04, revenue of $18.3M misses by $13.38M
08/07/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, August 7th, 2025
08/07/2025 05:31 AM EDT US Earnings Reports Expected earnings - Sangamo Therapeutics Inc.
07/31/2025 08:40 AM EDT Zacks Vanda Pharmaceuticals (VNDA) Reports Q2 Loss, Misses Revenue Estimates
06/24/2025 08:46 AM EDT SeekingAlpha Sangamo rises after trial data for Fabry disease therapy
05/13/2025 04:36 AM EDT SeekingAlpha Sangamo Therapeutics prices $23M securities offering
05/13/2025 01:00 AM EDT SeekingAlpha Sangamo Therapeutics misses top-line and bottom-line estimates; reaffirms FY25 outlook
05/12/2025 09:06 PM EDT SeekingAlpha Sangamo Therapeutics, Inc. (SGMO) Q1 2025 Earnings Call Transcript
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.